ATA-SNMMI Joint Session
FRIDAY, SEPTEMBER 12 | 9:10 AM – 11:10 AM

Join Leading Experts in a Critical Thyroid Care Case-Based Discussion
The American Thyroid Association and the Society of Nuclear Medicine & Molecular Imaging are bringing together renowned specialists for an essential dialogue on one of thyroid medicine’s most common questions: When should radioactive iodine therapy be used?

Discover cutting-edge insights that could transform your patient treatment decisions
Expert Panel Discussion: Watch as leading clinicians debate the evidence for and against RAI treatment in intermediate-risk thyroid cancer patients.
Latest Research Insights: Get up-to-speed on breakthrough redifferentiation strategies for patients with non-RAI-avid disease, including the most recent clinical trial data.
Pediatric Perspectives: Learn specialized approaches for RAI treatment in younger patients, where treatment decisions carry unique considerations.
Recurrent Disease Strategies: Explore evidence-based protocols for managing patients with recurrent thyroid cancer.

Why This Matters to Your Practice:
This unique session is your opportunity to hear directly from the experts shaping thyroid treatment. You’ll leave with practical insights to confidently navigate complex treatment decisions and provide the best possible care for your patients.
Perfect for: Endocrinologists, nuclear medicine physicians, oncologists, and healthcare professionals managing thyroid cancer patients.

Core Thyroidology Track – New This Year!

(more details coming soon)

Surgical Symposium
FRIDAY, SEPTEMBER 12 | 2:00 PM – 4:00 PM

(more details coming soon)

Pediatric Symposium
SATURDAY, SEPTEMBER 13 | 1:00 PM – 3:00 PM

(more details coming soon)